相关实验视频

Updated: Jul 12, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

目前对基于质谱的免疫组学的观点:瘤抗原发现的计算角度

Bing Zhang^1,2, Michal Bassani-Sternberg^3,4,5

¹Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA bing.zhang@bcm.edu Michal.Bassani@chuv.ch.

Journal for immunotherapy of cancer

|October 29, 2023

概括

识别由人类白细胞抗原 (HLA) 分子呈现的瘤抗原是癌症免疫治疗的关键. 蛋白质基因组分析将质谱与测序数据相结合,提高了瘤抗原的发现,以获得更有效的治疗方法.

科学领域:

免疫学免疫学免疫学
蛋白质组学是指蛋白质组学.
基因组学就是基因组学.

背景情况:

有效的癌症免疫疗法取决于识别T细胞识别的瘤抗原.
人类白细胞抗原 (HLA) 分子呈现这些瘤抗原.
基于质谱 (MS) 的免疫组学是直接识别的关键技术.

研究的目的:

概述增强瘤抗原识别的蛋白质基因学方法.
讨论免疫体学数据分析中的计算挑战和考虑.
为了突出使得更敏感和更准确的瘤抗原发现的进步.

主要方法:

HLA复合体的免疫亲和性净化,然后进行MS形状分析.
整合DNA,RNA和核糖体测序数据与免疫组学.
蛋白质基因组分析用于识别正规和非正规瘤抗原.

主要成果:

蛋白质基因组方法可以识别来自编码和非编码基因组区域的瘤抗原.
计算策略对于分析复杂的免疫组学和测序数据至关重要.
技术和计算方面的进步提高了瘤抗原识别的灵敏度和准确性.

结论:

蛋白质基因组分析显著提高了用于癌症免疫治疗的瘤抗原发现.
解决计算挑战对于成功实施这种方法至关重要.
持续的技术和计算进步有望提供更有效的癌症免疫疗法.

关键词:

抗原,新型细胞体计算生物学计算生物学豁免权是一种豁免权.

更多相关视频

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

相关概念视频

Peptide Identification Using Tandem Mass Spectrometry

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.